“This is the first time that we have had the ability to measure glutamate toxicity in the brain in real time, which gives us a marker for monitoring disease progression as well as our treatment of the ...

Neema et al. Deep Gray Matter Involvement on Brain MRI Scans Is Associated with Clinical Progression in Multiple Sclerosis. Journal of Neuroimaging , 2008; DOI: 10.1111/j.1552-6569.2008.00296.x ...

Clinical Applications of Imaging Disease Burden in Multiple Sclerosis MRI and Advanced Imaging ... Daniel Pelletier. Disclosures. Expert Rev Neurother. 2012;12(3):323-333. In This Article ...

Magnetic resonance imaging, or MRI, has revolutionized the diagnosis of multiple sclerosis. WebMD explains how MRI works in detecting MS abnormalities and tracking the progress of the disease.

Chronic active lesions -- dark-rimmed spots indicating ongoing, smoldering inflammation on 3T or 7T MRI susceptibility sequences -- were common in multiple sclerosis (MS) and tied to disability ...

MRI-based visualization of demyelinated CNS lesions is pivotal to the diagnosis and monitoring of multiple sclerosis (MS). The authors describe how advanced multimodal neuroimaging techniques are ...

A retrospective, five-year study of 1,314 patients with multiple sclerosis (MS) has found that atrophied brain lesion volume is the only marker from MRI scans that can accurately predict which ...

It is important to realize that both disease activity and current therapies can influence brain volume. Brain volume can transiently increase with the inflammation and edema that are associated ...